177 related articles for article (PubMed ID: 2174053)
1. Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis.
Reid GK; Kargman S; Vickers PJ; Mancini JA; Léveillé C; Ethier D; Miller DK; Gillard JW; Dixon RA; Evans JF
J Biol Chem; 1990 Nov; 265(32):19818-23. PubMed ID: 2174053
[TBL] [Abstract][Full Text] [Related]
2. A23187-induced translocation of 5-lipoxygenase in osteosarcoma cells.
Kargman S; Vickers PJ; Evans JF
J Cell Biol; 1992 Dec; 119(6):1701-9. PubMed ID: 1469057
[TBL] [Abstract][Full Text] [Related]
3. Regulation of 5-lipoxygenase and 5-lipoxygenase-activating protein expression in HL-60 cells.
Bennett CF; Chiang MY; Monia BP; Crooke ST
Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):33-9. PubMed ID: 8380989
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene synthesis in U937 cells expressing recombinant 5-lipoxygenase.
Kargman S; Rousseau P; Reid GK; Rouzer CA; Mancini JA; Rands E; Dixon RA; Diehl RE; Léveillé C; Nathaniel D
J Lipid Mediat; 1993 May; 7(1):31-45. PubMed ID: 8358023
[TBL] [Abstract][Full Text] [Related]
5. 5-lipoxygenase-activating protein is an arachidonate binding protein.
Mancini JA; Abramovitz M; Cox ME; Wong E; Charleson S; Perrier H; Wang Z; Prasit P; Vickers PJ
FEBS Lett; 1993 Mar; 318(3):277-81. PubMed ID: 8440384
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
[TBL] [Abstract][Full Text] [Related]
7. Human bronchial fibroblasts express the 5-lipoxygenase pathway.
James AJ; Penrose JF; Cazaly AM; Holgate ST; Sampson AP
Respir Res; 2006 Jul; 7(1):102. PubMed ID: 16872537
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor.
Brideau C; Chan C; Charleson S; Denis D; Evans JF; Ford-Hutchinson AW; Fortin R; Gillard JW; Guay J; Guévremont D
Can J Physiol Pharmacol; 1992 Jun; 70(6):799-807. PubMed ID: 1330258
[TBL] [Abstract][Full Text] [Related]
9. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis.
Dixon RA; Diehl RE; Opas E; Rands E; Vickers PJ; Evans JF; Gillard JW; Miller DK
Nature; 1990 Jan; 343(6255):282-4. PubMed ID: 2300173
[TBL] [Abstract][Full Text] [Related]
10. Regulation of leukotriene-biosynthetic enzymes during differentiation of myelocytic HL-60 cells to eosinophilic or neutrophilic cells.
Scoggan KA; Nicholson DW; Ford-Hutchinson AW
Eur J Biochem; 1996 Aug; 239(3):572-8. PubMed ID: 8774699
[TBL] [Abstract][Full Text] [Related]
11. In situ amplification of 5-lipoxygenase and 5-lipoxygenase-activating protein in allergic airway inflammation and inhibition by leukotriene blockade.
Chu SJ; Tang LO; Watney E; Chi EY; Henderson WR
J Immunol; 2000 Oct; 165(8):4640-8. PubMed ID: 11035107
[TBL] [Abstract][Full Text] [Related]
12. On the expression and regulation of 5-lipoxygenase in human lymphocytes.
Jakobsson PJ; Steinhilber D; Odlander B; Rådmark O; Claesson HE; Samuelsson B
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3521-5. PubMed ID: 1314391
[TBL] [Abstract][Full Text] [Related]
13. Translocation of HL-60 cell 5-lipoxygenase. Inhibition of A23187- or N-formyl-methionyl-leucyl-phenylalanine-induced translocation by indole and quinoline leukotriene synthesis inhibitors.
Kargman S; Prasit P; Evans JF
J Biol Chem; 1991 Dec; 266(35):23745-52. PubMed ID: 1748650
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene receptors and mechanisms of signal transduction.
Crooke ST; Monia BP; Chiang MY; Bennett CF
Ann N Y Acad Sci; 1991; 629():120-4. PubMed ID: 1952543
[TBL] [Abstract][Full Text] [Related]
15. 5-Lipoxygenase-activating protein is the target of a quinoline class of leukotriene synthesis inhibitors.
Evans JF; Lévillé C; Mancini JA; Prasit P; Thérien M; Zamboni R; Gauthier JY; Fortin R; Charleson P; MacIntyre DE
Mol Pharmacol; 1991 Jul; 40(1):22-7. PubMed ID: 1857337
[TBL] [Abstract][Full Text] [Related]
16. 5-Lipoxygenase activating protein (FLAP) dependent leukotriene biosynthesis inhibition (MK591) attenuates Lipid A endotoxin-induced inflammation.
Fang WF; Douglas IS; Wang CC; Kao HC; Chang YT; Tseng CC; Huang KT; Chang HC; Lin MC
PLoS One; 2014; 9(7):e102622. PubMed ID: 25025775
[TBL] [Abstract][Full Text] [Related]
17. Effect of dexamethasone on leukotriene synthesis in DMSO-stimulated HL-60 cells.
Zaitsu M; Hamasaki Y; Yamamoto S; Kita M; Hayasaki R; Muro E; Kobayashi I; Matsuo M; Ichimaru T; Miyazaki S
Prostaglandins Leukot Essent Fatty Acids; 1998 Dec; 59(6):385-93. PubMed ID: 10102384
[TBL] [Abstract][Full Text] [Related]
18. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
Lee E; Lindo T; Jackson N; Meng-Choong L; Reynolds P; Hill A; Haswell M; Jackson S; Kilfeather S
Am J Respir Crit Care Med; 1999 Dec; 160(6):2079-85. PubMed ID: 10588632
[TBL] [Abstract][Full Text] [Related]
19. FLAP: a novel drug target for inhibiting the synthesis of leukotrienes.
Ford-Hutchinson AW
Trends Pharmacol Sci; 1991 Feb; 12(2):68-70. PubMed ID: 2024291
[TBL] [Abstract][Full Text] [Related]
20. BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assembly.
Garscha U; Voelker S; Pace S; Gerstmeier J; Emini B; Liening S; Rossi A; Weinigel C; Rummler S; Schubert US; Scriba GK; Çelikoğlu E; Çalışkan B; Banoglu E; Sautebin L; Werz O
Biochem Pharmacol; 2016 Nov; 119():17-26. PubMed ID: 27592027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
